Aprea Therapeutics (APRE) Misses Q1 EPS by 66c
Tweet
Share
E-mailGet Alerts APRE Hot Sheet
Join SI Premium – FREE
Aprea Therapeutics (NASDAQ: APRE) reported Q1 EPS of ($0.66).
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
- ACNB Corporation (ACNB) Tops Q2 EPS by 11c
- Kearny Financial (KRNY) Misses Q4 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
